Cargando...
Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
Medulloblastoma is the most common malignant childhood brain tumor, and 5-year overall survival rates are as low as 40% depending on molecular subtype, with new therapies critically important. As radiotherapy and chemotherapy act through the induction of DNA damage, the sensitization of cancer cells...
Guardado en:
| Publicado en: | Front Mol Biosci |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8116896/ https://ncbi.nlm.nih.gov/pubmed/33996894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2021.633344 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|